Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: Preliminary results in Vietnam

被引：0
|
作者：
Hoang, G. H. Nguyen [1 ]
Nguyen, P. T. B. [2 ]
Nguyen, H. T. N. [2 ]
Do, K. H. [2 ]
机构：
[1] Hanoi Oncol Hosp, Med Dept 1, Hanoi, Vietnam
[2] K Hosp, Med Dept 1, Hanoi, Vietnam
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
275P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
    Bergner, Nicole
    Monsef, Ina
    Illerhaus, Gerald
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [32] Stereotactic radiosurgery in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma
    Long, H.
    ANNALS OF ONCOLOGY, 2017, 28 : 36 - 36
  • [33] Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma
    Joerger, M.
    Huitema, A. D. R.
    Illerhaus, G.
    Ferreri, A. J. M.
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1867 - 1875
  • [34] SUCCESSFUL TREATMENT OF RECURRENT PRIMARY CENTRAL NERVOUS-SYSTEM LYMPHOMA WITH HIGH-DOSE METHOTREXATE
    ERVIN, T
    CANELLOS, GP
    CANCER, 1980, 45 (07) : 1556 - 1557
  • [35] PRIMARY CNS LYMPHOMA TREATED WITH HIGH-DOSE METHOTREXATE AND RITUXIMAB - SINGLE INSTITUTION EXPERIENCE
    Mrugala, M. M.
    Crew, L. K.
    NEURO-ONCOLOGY, 2012, 14 : 84 - 84
  • [36] White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab (vol 145, pg 461, 2019)
    Estephan, Fayez
    Ye, Xiaobu
    Dzaye, Omar
    Wagner-Johnston, Nina
    Swinnen, Lode
    Gladstone, Douglas E.
    Ambinder, Rich
    Kamson, David Olayinka
    Lambrecht, Sebastian
    Grossman, Stuart A.
    Lin, Doris D. M.
    Holdhoff, Matthias
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (03) : 467 - 467
  • [37] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: HIGH-DOSE METHOTREXATE PLUS RADIOTHERAPY, BETTER TREATMENT FOR ALL?
    Gonzalez-Domingo, M.
    Gonzalez-San Segundo, C.
    Menarguez, J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S361 - S362
  • [38] Risk factors for high-dose methotrexate associated toxicities in patients with primary central nervous system lymphoma
    Sun, Kai
    Tao, Hongwei
    Ding, Tianling
    Li, Ziran
    Qiu, Xiaoyan
    Zhong, Mingkang
    Wu, Zhuo
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (12) : 2196 - 2204
  • [39] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: HIGH-DOSE METHOTREXATE PLUS RADIOTHERAPY, BETTER TREATMENT FOR ALL?
    Gonzalez-Domingo, M.
    Gonzalez-San Segundo, C.
    Menarguez, J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : X - X
  • [40] THERAPEUTIC EFFECT OF INDUCTION OF POLYGLUTAMYLATION IN HIGH-DOSE METHOTREXATE THERAPY TO PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Fujimoto, Kenji
    Shinojima, Naoki
    Makino, Keishi
    Ichimura, Koichi
    Mukasa, Akitake
    NEURO-ONCOLOGY, 2019, 21 : 34 - 34
12345